Research and Development
Takeda presents long-term Entyvio data in CD and UC
March 21, 2016 Manufacturing and Production, Research and Development Crohn's, Crohn's and Colitis, Entyvio, Takeda, ulcerative colitis
ThromboGenics signs €1m licensing deal with Galapagos for diabetic eye disease treatment
March 21, 2016 Manufacturing and Production, Research and Development, Sales and Marketing
European Medicines Agency elects Christa Wirthumer-Hoche as new chair of management board
March 21, 2016 Medical Communications, Research and Development Christa Wirthumer-Hoche, EMA, European Medicines Agency, chair, chairperson, wirthumer-hoche
Leo Pharma gets EU scientific approval for its psoriasis drug Enstilar
March 21, 2016 Business Services, Research and Development, Sales and Marketing EU, Enstilar, LEO Pharma, psoriasis vulgaris
Novartis’s heart failure drug given final recommendation by NICE
March 21, 2016 Manufacturing and Production, Research and Development Entresto, NICE, Novartis, approval, draft, guidance, heart failure, heart failure drug
TREND: Smallcap biotechs win in stock markets on positive drug trials
March 21, 2016 Research and Development, Sales and Marketing
Further positive trial results boost Amgen and UCB’s romosozumab
March 21, 2016 Research and Development, Sales and Marketing Amgen, Romosozumab, UCB, clinical trial, osteoporosis, phase 3, phase III, regulatory approval
Celgene’s ozanimod meets endpoints in Phase II ulcerative colitis trials
March 21, 2016 Research and Development, Sales and Marketing Celgene
US FDA rejects application for Eagle Pharma’s blood thinner; shares plunge
March 21, 2016 Research and Development, Sales and Marketing Eagle Pharmaceuticals, Kangio, US FDA, blood thinner
Pfizer’s JAK inhibitor meets endpoints in Phase III ulcerative colitis trials
March 21, 2016 Research and Development, Sales and Marketing JAK inhibitor, Pfizer, ecco, endpoint, octave, tofacitinib, ulcerative colitis
J&J says psoriasis drug Stelara shows positive results in trials for Crohn’s disease
March 18, 2016 Medical Communications, Research and Development Crohn’s disease, J&J, JJ, Stelara, crohn's disease
Wales approve pancreatic cancer drug for use despite NICE rejection in England
March 18, 2016 Medical Communications, Research and Development Abraxane, Celgene, England, NHS, NICE, Wales, approval
Study data supports switch to Celltrion’s Remicade biosimilar
March 18, 2016 Research and Development
OncoMed initiates Phase Ib immuno-oncology combination clinical trial
March 18, 2016 Medical Communications, Research and Development Merck, OncoMed, clinical trial, demcizumab, immuno-oncology, immuno-oncology combination, pembrolizumab, phase ib
Gilead cancer boss departs after safety concerns halt Zydelig trials
March 18, 2016 Medical Communications, Research and Development Gilead Sciences, zydelig
